Market
Oracle's AI cancer treatment project gets major regulatory approval by mid-2025?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Announcements from regulatory bodies such as the FDA or equivalent international agencies
Story
Oracle CEO Larry Ellison Announces AI-Designed mRNA Cancer Vaccines in 48 Hours, Highlights Early Detection in White House Project Starship
Jan 21, 2025, 11:04 PM
Larry Ellison, CEO of Oracle, announced at the White House that artificial intelligence (AI) will soon enable the design of personalized mRNA vaccines for cancer treatment within 48 hours. Ellison emphasized the potential of AI in early cancer detection and the development of tailored therapies, stating, "This is the promise of AI." He highlighted the ongoing work to utilize AI for gene sequencing of tumors, which would facilitate the creation of customized vaccines. Ellison's vision reflects a broader commitment to revolutionizing healthcare through technology, aiming to redefine cancer treatment and improve patient outcomes.
View original story
Similar markets
No • 50%
Yes • 50%
No • 50%
Yes • 50%
Other • 25%
Johnson & Johnson • 25%
Moderna • 25%
Pfizer • 25%
Pfizer • 25%
Other • 25%
Johnson & Johnson • 25%
Moderna • 25%
Cancer Vaccines • 25%
Pandemic Prevention • 25%
Other • 25%
Personalized Medicine • 25%
Breast Cancer • 25%
Other • 25%
Lung Cancer • 25%
Prostate Cancer • 25%